[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640677":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":22,"collaborators":7,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":7,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":34,"maxAge":35,"enrollmentInfo":36,"targetDuration":7,"studyType":39,"phases":7,"briefSummary":40,"conditions":41,"keywords":7,"overallStatus":43,"whyStopped":7,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":7},{"fullName":5,"class":6},"Ain Shams University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Hysteroscopic Myomectomy","Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Yomna Ayman Salah, Master degree","CONTACT","01060666006","yomnasalah@med.asu.edu.eg",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":7},"Ahmed Mohammed Selim, MD","011 15330063",{"type":23,"investigatorFullName":24,"investigatorTitle":25,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Yomna Ayman Salah Abbas","Doctor","100640677","evaluating-the-applicability-of-lasmar-scoring-in-predicting-surgical-outcomes-of-hysteroscopic-myomectomy-100640677",false,"NCT07578246","\"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy\"","Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy\"","Inclusion Criteria:\n\n* Women aged 18-45 years\n* Type 0,1,2 Fibroids according to Figo classification.\n* Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.\n* Fibroids size ≤ 5 cm in diameter\n* Confirmed diagnosis of leiomyoma by ultrasound .\n* Hemodynamically Stable Patients: Patients with no significant anemia.\n\nExclusion Criteria:\n\n* Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)\n* Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).\n* Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).\n* Fibroid Size\\>5 cm.","FEMALE","18 Years","45 Years",{"count":37,"type":38},88,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.",[42],"LAZMAR Scoring , Hysteroscopic Myomectomy","NOT_YET_RECRUITING","2026-05-05",{"date":46,"type":47},"2026-05-11","ACTUAL",{"date":49,"type":38},"2026-06-01",{"date":51,"type":38},"2028-07-01",{"name":5,"class":6}]